Cargando…

COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation

Activation of EGFR is a major risk factor for non-small cell lung cancer (NSCLC). Understanding the molecular events promoting EGFR activation can help us gain more insights into the progression of NSCLC. In this study, we demonstrate that collagen type VIII alpha 1 chain (COL8A1), an extracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Zan, Xiangyi, Li, Shuyan, Wei, Shixiong, Gao, Liping, Zhao, Lanting, Yan, Xiaoxia, Zhao, Yan, Shi, Junnian, Wang, Yuping, Liu, Rong, Zhang, Yuanyi, Wan, Yixin, Zhou, Yongning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907630/
https://www.ncbi.nlm.nih.gov/pubmed/35280763
http://dx.doi.org/10.3389/fonc.2022.707525
_version_ 1784665691869151232
author Zan, Xiangyi
Li, Shuyan
Wei, Shixiong
Gao, Liping
Zhao, Lanting
Yan, Xiaoxia
Zhao, Yan
Shi, Junnian
Wang, Yuping
Liu, Rong
Zhang, Yuanyi
Wan, Yixin
Zhou, Yongning
author_facet Zan, Xiangyi
Li, Shuyan
Wei, Shixiong
Gao, Liping
Zhao, Lanting
Yan, Xiaoxia
Zhao, Yan
Shi, Junnian
Wang, Yuping
Liu, Rong
Zhang, Yuanyi
Wan, Yixin
Zhou, Yongning
author_sort Zan, Xiangyi
collection PubMed
description Activation of EGFR is a major risk factor for non-small cell lung cancer (NSCLC). Understanding the molecular events promoting EGFR activation can help us gain more insights into the progression of NSCLC. In this study, we demonstrate that collagen type VIII alpha 1 chain (COL8A1), an extracellular matrix component, was overexpressed in NSCLC. In NSCLC cells, knockdown of COL8A1 suppressed cell growth, cycle progression, and migration, and induced cell apoptosis. While COL8A1 overexpression promoted cell proliferation and inhibited cell apoptosis. In addition, we found that COL8A1 depletion reduced interferon response signaling and downregulated (IFIT1) and interferon-induced proteins with tetratricopeptide repeats 3 (IFIT3). Moreover, we indicated that COL8A1 could upregulate IFIT1 and IFIT3 mediated EGFR activation in vitro and in vivo. Lastly, there was a positive correlation among COL8A1, IFIT1, and IFIT3 expression, and EGFR activity in patients with NSCLC. Overall, our data demonstrate that COL8A1 contributes to NSCLC proliferation and invasion through EGFR activation, dependent on IFIT1 and IFIT3 expression.
format Online
Article
Text
id pubmed-8907630
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89076302022-03-11 COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation Zan, Xiangyi Li, Shuyan Wei, Shixiong Gao, Liping Zhao, Lanting Yan, Xiaoxia Zhao, Yan Shi, Junnian Wang, Yuping Liu, Rong Zhang, Yuanyi Wan, Yixin Zhou, Yongning Front Oncol Oncology Activation of EGFR is a major risk factor for non-small cell lung cancer (NSCLC). Understanding the molecular events promoting EGFR activation can help us gain more insights into the progression of NSCLC. In this study, we demonstrate that collagen type VIII alpha 1 chain (COL8A1), an extracellular matrix component, was overexpressed in NSCLC. In NSCLC cells, knockdown of COL8A1 suppressed cell growth, cycle progression, and migration, and induced cell apoptosis. While COL8A1 overexpression promoted cell proliferation and inhibited cell apoptosis. In addition, we found that COL8A1 depletion reduced interferon response signaling and downregulated (IFIT1) and interferon-induced proteins with tetratricopeptide repeats 3 (IFIT3). Moreover, we indicated that COL8A1 could upregulate IFIT1 and IFIT3 mediated EGFR activation in vitro and in vivo. Lastly, there was a positive correlation among COL8A1, IFIT1, and IFIT3 expression, and EGFR activity in patients with NSCLC. Overall, our data demonstrate that COL8A1 contributes to NSCLC proliferation and invasion through EGFR activation, dependent on IFIT1 and IFIT3 expression. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8907630/ /pubmed/35280763 http://dx.doi.org/10.3389/fonc.2022.707525 Text en Copyright © 2022 Zan, Li, Wei, Gao, Zhao, Yan, Zhao, Shi, Wang, Liu, Zhang, Wan and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zan, Xiangyi
Li, Shuyan
Wei, Shixiong
Gao, Liping
Zhao, Lanting
Yan, Xiaoxia
Zhao, Yan
Shi, Junnian
Wang, Yuping
Liu, Rong
Zhang, Yuanyi
Wan, Yixin
Zhou, Yongning
COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
title COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
title_full COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
title_fullStr COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
title_full_unstemmed COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
title_short COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
title_sort col8a1 promotes nsclc progression through ifit1/ifit3-mediated egfr activation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907630/
https://www.ncbi.nlm.nih.gov/pubmed/35280763
http://dx.doi.org/10.3389/fonc.2022.707525
work_keys_str_mv AT zanxiangyi col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT lishuyan col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT weishixiong col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT gaoliping col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT zhaolanting col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT yanxiaoxia col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT zhaoyan col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT shijunnian col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT wangyuping col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT liurong col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT zhangyuanyi col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT wanyixin col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation
AT zhouyongning col8a1promotesnsclcprogressionthroughifit1ifit3mediatedegfractivation